Journal profile · Medicine-Cardiology and Cardiovascular Medicine
Frontiers in Cardiovascular Medicine
ISSN 2297-055X · Frontiers Media S.A. · SWITZERLAND
Frontiers in Cardiovascular Medicine: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 2.98; fully open access; APC charged, amount not published; median 78 days to acceptance (198 articles, last 24 months); 1,804 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Frontiers in Cardiovascular Medicine is published by Frontiers Media S.A. and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Cardiovascular Function and Risk Factors, Atrial Fibrillation Management and Outcomes and Cardiac Valve Diseases and Treatments, together about 24% of its articles. Its main subfields are Cardiology and Cardiovascular Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Frontiers in Cardiovascular Medicine is a multidisciplinary journal that publishes research articles across basic, translational, and clinical cardiovascular medicine. Led by Field Chief Editors Dr Masanori Aikawa (Brigham Women’s Hospital, USA) and Dr Hendrik Tevaearai Stahel (University Hospital of Bern, Switzerland) Frontiers in Cardiovascular Medicine covers all aspects of cardiovascular medicine, with an emphasis on studies that challenge the status quo of treatments and practices or facilitate the translation of scientific advances into the clinic. Topics include, but are not limited to: • atherosclerosis and vascular medicine • cardiac rhythmology • cardio-oncology • cardioneurology • cardiovascular epidemiology and prevention • cardiovascular genetics and systems medicine • cardiovascular imaging • cardiovascular metabolism • cardiovascular nursing • cardiovascular pharmacology and drug discovery • cardiovascular surgery • clinical and translational cardiovascular medicine • coronary artery disease • general cardiovascular medicine • heart failure and transplantation • heart valve disease • hypertension • intensive care cardiovascular medicine • lipids in cardiovascular disease • pediatric cardiology • precision cardiology • sex and gender in cardiovascular medicine • structural interventional cardiology • thrombosis and haemostasis. Both fundamental mechanistic studies of cardiovascular disease and translational research that can bring new discoveries to patients quickly are welcome. The editors are especially interested in submissions that employ a systems approach driven by data science. Frontiers’ journals require that manuscripts primarily comprising computational studies of public data, such as NHANES or Mendelian Randomization studies, must include appropriate validation. The journal is not considering bibliometric studies. Please refer to the Frontiers Standards for research methodology policy, for more information. Manuscripts not adhering to these standards will not be considered. In particular, the journal welcomes submissions that support and advance the UN’s Sustainable Development Goal (SDG), notably SDG#3: Ensure healthy lives and promote well-being for all at all ages. Frontiers in Cardiovascular Medicine is committed to advancing developments in the field of cardiovascular medicine by allowing unrestricted access to articles, and communicating scientific knowledge to researchers and the public alike, to enable the scientific breakt
From the journal's Aims & Scope
Research area (LetPub): Medicine-Cardiology and Cardiovascular Medicine
Editorial board by country: none in mainland China; most named United States 5, United Kingdom 4, Italy 3, Switzerland 2, Germany 1 (16 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cardiovascular Function and Risk FactorsMedicine9.4%
- Atrial Fibrillation Management and OutcomesMedicine7.3%
- Cardiac Valve Diseases and TreatmentsMedicine7.3%
- Cardiac Imaging and DiagnosticsMedicine6.7%
- Aortic Disease and Treatment ApproachesMedicine5%
- Coronary Interventions and DiagnosticsMedicine4.9%
- Cardiac Arrhythmias and TreatmentsMedicine4.8%
- Heart Failure Treatment and ManagementMedicine4.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Cardiac & Cardiovascular Systems | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Cardiac & Cardiovascular Systems | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Cardiac & Cardiovascular Systems | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of SciencePMCEmbasePublisher website
Other: EBSCO, ProQuest, Dimensions, CNKI, CLOCKSS, Crossref
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.98LetPub ·
- Impact factor (publisher)
- 3Publisher website ·
- CiteScore 2026-06
- 6.1LetPub ·
- CiteScore (publisher)
- 6.1Publisher website ·
- SJR 2026-06
- 0.97LetPub ·
- SNIP 2026-06
- 1.06LetPub ·
- h-index
- 118OpenAlex ·
- i10-index
- 4,962OpenAlex ·
- 2-year mean citedness
- 2.44OpenAlex ·
- Self-citation rate
- 3.3%LetPub ·
- Share of gold OA articles
- 99.94%LetPub ·
Volume
- Articles per year
- 1,706LetPub ·
Articles by year OpenAlex count · 14,950 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 2,219 | 2,219 | 577 |
| 2025 | 1,804 | 1,804 | 4,303 |
| 2024 | 1,561 | 1,561 | 8,756 |
| 2023 | 2,434 | 2,434 | 23,459 |
| 2022 | 3,960 | 3,960 | 55,991 |
| 2021 | 2,033 | 2,033 | 40,866 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
78 daysMedian, submission to acceptance · P25–P75 51 days – 115 days
- Acceptance to online
- median 16 days (198 articles)
- Submission to online
- median 97 days
- Sample
- 198 articles with submission and acceptance dates (4,273 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 14 weeksLetPub ·
- Submission to publication (journal-reported)
- about 14 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | CHF 3,150 | Yes | CC BY | |
| OpenAlex | CHF 3,150 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Keywords
- 5–8
- Reference style
- Harvard
- Templates
- LaTeX and Word
Policy excerpts from the journal's websiteAI use, Conflicts of interest, License & copyright, Open access, Peer review
- AI use Use of AI to create written or visual content
Authors should not list a generative AI technology as a co-author or author of any submitted manuscript. Generative AI technologies cannot be held accountable for all aspects of a manuscript and consequently do not meet the criteria required for authorship. If the author of a submitted manuscript has used written or visual content produced by or edited using a generative AI technology, this use mu…
Source ↗Publisher website ·- Conflicts of interest Safeguards against financial conflicts of interest
Only leading researchers acting as Associate Editors, who are not part of Frontiers' staff, can make acceptance decisions based on reviews performed by external experts acting as Community Reviewers or Reviewers. None have a financial incentive to accept articles, i.e. they are not paid for their role as Associate Editor or community Reviewer, and any award scheme is not linked to acceptances of m…
Source ↗Publisher website ·- License & copyright Open access and copyright
All Frontiers' articles from July 2012 onwards are published with open access under the Creative Commons CC-BY license (the current version is CC-BY, version 4.0). This means that the author(s) retains copyright, but the content is free to download, distribute, and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article. Upon submission, the author(s)…
Source ↗Publisher website ·- Open access Open access and copyright
All Frontiers' articles from July 2012 onwards are published with open access under the Creative Commons CC-BY license (the current version is CC-BY, version 4.0). This means that the author(s) retains copyright, but the content is free to download, distribute, and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article. Upon submission, the author(s)…
Source ↗Publisher website ·- Peer review Peer review
Our rigorous, transparent peer review process combines expert review and constructive dialogue to strengthen your manuscript.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Frontiers Media S.A.
- Country or region
- SWITZERLAND
- Language
- English
- ISSN
- 2297-055X
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Frontiers in Cardiovascular Medicine
What CAS zone is Frontiers in Cardiovascular Medicine in?
In the 2025 upgraded edition of the CAS Journal Ranking, Frontiers in Cardiovascular Medicine is in Zone 3 of Medicine, and in Zone 3 of the minor category Cardiac & Cardiovascular Systems. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Frontiers in Cardiovascular Medicine?
The latest impact factor listed by LetPub is 2.98; CiteScore 6.1, h-index 118.
How long does peer review take at Frontiers in Cardiovascular Medicine?
Based on the dates recorded on 198 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 78 days (interquartile range 51–115 days); authors report an average review time of about 14 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Frontiers in Cardiovascular Medicine?
According to the journal's author guidelines: Keywords: 5–8; Reference style: Harvard; Templates: LaTeX and Word. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Frontiers in Cardiovascular Medicine based?
Of the 16 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (5), United Kingdom (4) and Italy (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Frontiers in Cardiovascular Medicine?
According to LetPub and DOAJ records, Frontiers in Cardiovascular Medicine is indexed in SCIE, Scopus and DOAJ. The journal's website also lists Web of Science, PMC and Embase; that list has not been checked against each database.
Is Frontiers in Cardiovascular Medicine open access, and what is the APC?
Frontiers in Cardiovascular Medicine is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .